(Press-News.org) When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in disease progression. Disrupt them and negate whatever role they play in cancer’s development or spread. Researchers at Cold Spring Harbor Laboratory (CSHL) have also been working on another kind of target. They’re studying a long non-coding RNA called MALAT1. So far, it’s been linked to more than 20 different types of tumors.
In a new and unique study published in Molecular Therapy: Oncology, CSHL researchers track MALAT1 levels over the course of one woman’s experience with triple-negative breast cancer (TNBC). They find that MALAT1 levels were high at diagnosis and decreased while the patient received standard treatments. Yet, perhaps most importantly, the level increased at a distant metastatic site. The researchers see this as supporting a role for MALAT1 in TNBC’s spread.
The study allowed CSHL to interrogate this potential treatment target like never before. “Even though MALAT1 has been implicated in different cancers, including breast cancer, nobody has looked at how MALAT1 levels change over treatment and disease progression,” says Disha Aggarwal, the graduate student who spearheaded the study.
Researchers examined tissue samples from a 59-year-old woman diagnosed with stage 1 TNBC. The patient underwent different treatments over two and a half years, including surgery, chemotherapy, radiation, and immunotherapy. After a period of regression, the cancer became metastatic. Unfortunately, three and a half years after diagnosis, the individual succumbed to the disease. However, what she left behind will hopefully help others.
Studying tissue samples from throughout the course of treatment and disease progression presented a rare opportunity, says CSHL Professor David Spector. “Researchers typically get to see an initial sample and an end sample, but not progressive samples in the depth that we were able to look at here.” What they’ve seen may eventually inform future treatments.
Since 2015, the Spector lab has been collaborating with Ionis Pharmaceuticals to develop a drug targeting MALAT1. They’re now speaking with biotech companies in hopes of launching a clinical trial within the next few years. But that’s not all.
Spector’s lab is also exploring whether MALAT1 could enable doctors to predict the risk of someone’s cancer recurring or becoming metastatic. If so, it could not only guide therapeutic strategies for women who have been diagnosed with TNBC. It could factor in for those with more common and less severe forms of breast cancer.
END
Breast cancer case study could inform clinical trials
2025-11-10
ELSE PRESS RELEASES FROM THIS DATE:
Cherie Zachary, MD, installed as ACAAI President
2025-11-10
ORLANDO (NOV. 9, 2025) – Allergist Cherie Zachary, MD, of Bloomington, MN was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the ACAAI Annual Scientific Meeting on November 10 in Orlando. Allergist David Stukus, MD, of Columbus, OH, was elected ACAAI president-elect.
Other newly-elected ACAAI officers are Maureen Petersen, MD, of Clayton, NC, as vice president and Melinda Rathkopf, MD, MBA, of Atlanta, GA, as treasurer. Regents elected for three-year terms include Christopher C. Chang, MD, PhD, MBA, Hollywood, Florida, Mitchell H. Grayson, MD, Columbus, OH, and Jay A. Lieberman, ...
Billions live in environments that violate human rights
2025-11-10
More than 99% of the world’s 7.7 billion people have one or more of their environmental rights threatened, according to new research.
In the most comprehensive analysis of inequality in environmental conditions to date, CU Boulder researchers revealed that nearly half of the global population lives in regions facing three or more environmental problems. Those include polluted air, unsafe water, extreme heat, food insecurity and biodiversity loss.
The analysis was published September 25 in Environmental Research Communications.
It provides strong ...
Thyroid gland new possible target for prostate cancer treatment
2025-11-10
A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new study by an international research group led by Umeå University, Sweden, and the Medical University of Vienna, Austria. By blocking a receptor for the hormone, the growth of tumour cells in the prostate was inhibited. In the long term, the discovery may open up a new way of attacking certain types of aggressive prostate cancer.
"The results indicate that the receptor in question is a driving force in the growth of cancer. Substances that block it could thus be a target for future drugs against prostate cancer," ...
New study reveals devastating impact of cane toads approaching the Pilbara
2025-11-10
New Curtin University research has found invasive cane toads are on track to reach Western Australia’s Pilbara region within the next 10 to 20 years, threatening to cause widespread losses among native species and significant cultural and economic harm.
The study, published in Scientific Reports, predicts that without containment efforts, the toxic amphibians will colonise up to 75 per cent of the Pilbara within three decades, putting 25 native species at risk of serious population declines. These include several species of native marsupial predators like northern quolls, ghost bat and kaluta, as well as frog-eating snakes, blue-tongue skinks and goannas.
Of ...
COP30: Global nature goals at risk as conservation projects quietly fail
2025-11-10
As world leaders begin COP30 climate negotiations in Brazil this week, an international team co-led by a University of Sydney researcher has warned of a hidden crisis undermining global biodiversity and carbon targets: the quiet abandonment of conservation projects.
The comment paper, ‘Conservation abandonment is a policy blind spot’, published in Nature Ecology & Evolution, was co-led by Dr Matthew Clark, a postdoctoral researcher in the Thriving Oceans Research Hub at the University of Sydney and an honorary research associate in the Centre for Environmental Policy at Imperial College ...
New treatment for combating iron deficiency more effectively
2025-11-10
Iron deficiency is globally widespread. Women are particularly affected, with one in five in Europe suffering from iron deficiency. The consequences are anaemia, constant fatigue, chronic headaches and a weakened immune system. Researchers led by ETH professor Raffaele Mezzenga have now developed a new dietary supplement that could efficiently treat iron deficiency and anaemia. This development is being co-led by Michael B. Zimmermann, professor emeritus at ETH Zurich. The preparation consists of edible oat protein ...
A new AI-powered method to automate material analysis and design
2025-11-10
Understanding the properties of different materials is an important step in material design. X-ray absorption spectroscopy (XAS) is an important technique for this, as it reveals detailed insights about a material’s composition, structure, and functional characteristics. The technique works by directing a beam of high-energy X-rays at a sample and recording how X-rays of different energy levels are absorbed. Similar to how white light splits into a rainbow after passing through a prism, XAS produces a spectrum of X-rays with different energies. This spectrum is called as spectral data, which acts like an unique fingerprint of a material, ...
Security flaws in portable genetic sequencers risk leaking private DNA data
2025-11-10
Portable genetic sequencers used around the world to sequence DNA have critical, previously unreported security vulnerabilities that could reveal or alter genetic information without detection, according to a new study.
Researchers from the University of Florida have, for the first time, exposed these security risks in devices from Oxford Nanopore Technologies, which produces nearly all the portable genetic sequencers in the world.
Alerted by the security researchers, Oxford Nanopore Technologies has rolled out updated software to patch the vulnerabilities. But out-of-date software, or unsecured internet systems, could still leave some DNA sequencers vulnerable ...
‘Roadmap’ shows the environmental impact of AI data center boom
2025-11-10
ITHACA, N.Y. - As the everyday use of AI has exploded in recent years, so have the energy demands of the computing infrastructure that supports it. But the environmental toll of these large data centers, which suck up gigawatts of power and require vast amounts of water for cooling, has been too diffuse and difficult to quantify.
Now, Cornell researchers have used advanced data analytics – and, naturally, some AI, too – to create a state-by-state look at that environmental impact. The team found that, by 2030, the current rate of AI growth would annually put 24 to 44 million metric tons of carbon dioxide into the ...
Scientists discover chameleon’s telephone-cord-like optic nerves once overlooked by Aristotle and Newton
2025-11-10
Chameleons’ wandering eyes have fascinated and puzzled scientists since the days of ancient Greece. Now, after millennia of study, modern imaging has revealed the secret of their nearly 360-degree view and uncanny ability to look in two different directions at once. Behind their bulging eyes lie two long, coiled optic nerves — a structure not seen in any other lizard.
“Chameleon eyes are like security cameras, moving in all directions,” explained Juan Daza, associate professor at Sam Houston State University and author of a new study describing the trait. “They ...